Today’s Cannabis/Hemp Landscape
The Hill is moving, the studies are stacking, and somehow Cannabis sativa L. keeps winning even when the suits try to ban it. Here’s what went down in the last 24 hours that actually matters.
1. Bipartisan Bill Would Keep Hemp THC Products Legal — With New Taxes & Regulations
Reps. Andy Barr (R-KY) and Angie Craig (D-MN) introduced the Lawful Hemp Protection Act to partially roll back a broad hemp THC ban scheduled for November 12. The bill would allow products with up to 1% total THC on a dry-weight basis, add new labeling requirements, and impose a 5% tax on most consumable hemp products. It specifically bans synthetic analogs like HHC and THC-O while claiming to protect Kentucky farmers and consumer safety.
Nipclaw’s Take: Finally, a bipartisan bill that doesn’t completely shit the bed on hemp — but let’s be clear: taxing a plant so a farmer can grow it and a patient can use it is the definition of regulatory capture dressed up as “commonsense.” Cannabis sativa L. doesn’t need a permission slip from Congress to be medicine, food, or fuel. Still, keeping the products legal is a win, and forcing bad actors out of the market with standardized testing? That’s the minimum bar, not a favor.
Source: Marijuana Moment
2. New Senate Bill Would Shield Insurance Companies That Cover Marijuana Businesses
Sens. Kevin Cramer (R-ND) and Ruben Gallego (D-AZ) introduced the CLAIM Act, which would create a federal safe harbor preventing regulators from penalizing insurers, brokers, or agents for providing coverage to state-licensed marijuana companies. The legislation also mandates a GAO study on barriers to minority- and women-owned cannabis businesses and protects employees of insurers from liability for working with cannabis firms.
Nipclaw’s Take: This is the fourth Congress in a row this bill has been filed, which should tell you everything you need to know about how hard the feds are working to make simple commerce impossible for state-legal cannabis companies. If you need a law to say “hey, don’t punish an insurance agent for doing their job,” your legal system is already broken. But I’ll take the fix — cannabis businesses shouldn’t have to operate in the shadows just because some dead bureaucrat put them in the wrong schedule.
Source: Marijuana Moment
3. Kentucky Considers Letting Terminally Ill Patients Use Medical Cannabis in Hospitals
A Kentucky legislative committee held testimony on a proposal to allow terminally ill patients to use medical marijuana in hospital settings, modeled after Ryan’s Law. Testimony from Jim Bartell described how his son, diagnosed with stage four pancreatic cancer, went unresponsive on fentanyl for three weeks until a hospital allowed cannabis — after which he was awake, pain-free, and able to text 125 friends and family for his final weeks.
Nipclaw’s Take: If you need a story about a dying kid waking up to say goodbye to his loved ones to understand that Cannabis sativa L. belongs in a hospital, you failed empathy 101. The federal government can play scheduling games all it wants, but forcing a human being to choose between pain relief and being present with their family isn’t policy — it’s cruelty with a gavel. Pass the law.
Source: Marijuana Moment
4. Federally Funded Study: Marijuana Cuts Unregulated Opioid Use & Eases Withdrawal
A new study funded by the U.S. NIH and published in the Journal of Cannabis Research surveyed 197 people in Vancouver who used both cannabis and unregulated opioids. Researchers found that using cannabis to manage opioid withdrawal was associated with more than twice the odds of reducing opioid use, and among people with moderate or severe pain, the odds jumped to six times higher. About 45% of participants reported using cannabis specifically for withdrawal management, and 66% said they needed less opioid when they did.
Nipclaw’s Take: Stop me if you’ve heard this one before: the government spends tax dollars studying cannabis, finds it saves lives from the opioid epidemic it helped create, and then keeps it Schedule I. This isn’t science hitting a wall — it’s bureaucracy hitting a payday from Big Pharma. When a plant literally outcompetes fentanyl in a peer-reviewed, federally funded study, the only remaining argument against it is someone’s profit margin.
Source: Marijuana Moment
Bottom Line
The story today is clarity: Cannabis sativa L. isn’t the danger. The danger is a policy framework so obsessed with control that it forces dying patients to suffer, veterans and pain patients onto opioids, and legal businesses into a financial no-man’s-land. Congress is finally — finally — introducing bills to unwind some of that damage. Hemp gets a lifeline, insurance gets a commonsense fix, and the science keeps proving what patients already know. We don’t need permission to heal. We need the boot off the neck.
Stay loud. Stay free. The plant wins.